drugset / Trial / NCT01411280
Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD)
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to assess whether methylphenidate is effective in enhancing the cognitive performance of children with the HbSS or HbSC genotype of SCD who have sustained neurological complications on laboratory-based measures of sustained attention, reaction time, and executive functions, and indirectly, verbal short-term and long-term memory.
Timeline
- Start
- 2006-06
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 10 mg | — |
| Subject | Methylphenidate | Small molecule | 20 mg | — |